Cargando…
When There Will Never be a Randomized Controlled Trial
There are many unanswered questions about how to best manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide editorial commentary on an observational study published in this edition of Kidney International that prese...
Autores principales: | Scialla, Julia J., Wolf, Myles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505498/ https://www.ncbi.nlm.nih.gov/pubmed/26230199 http://dx.doi.org/10.1038/ki.2015.123 |
Ejemplares similares
-
Ignorance is never bliss when it comes to patient care
por: van Zyl-Smit, Richard
Publicado: (2018) -
It’s never endometriosis, except when it’s endometriosis
por: Libretti, Alessandro, et al.
Publicado: (2023) -
Immunotherapy use outside clinical trial populations: never say never?
por: Rzeniewicz, K., et al.
Publicado: (2021) -
It's never too late to publish an abandoned trial
por: Shiles, Celia, et al.
Publicado: (2015) -
Never say never…
por: Schmidt, Laura A.
Publicado: (2021)